Dehydrocorydaline Exerts Anti-Pancreatic Cancer Effects Through the PI3K/Akt/mTOR Pathway.
Saved in:
| Title: | Dehydrocorydaline Exerts Anti-Pancreatic Cancer Effects Through the PI3K/Akt/mTOR Pathway. |
|---|---|
| Authors: | Yu, Qingmeng1 (AUTHOR), Li, Ruiding2 (AUTHOR), Li, Zhengyu1,2 (AUTHOR), Wan, Zhexin1,2 (AUTHOR), Lv, Kaikai2 (AUTHOR), He, Chongyang1 (AUTHOR), Sun, Jianfang2 (AUTHOR), Jia, Shubing1 (AUTHOR), Xu, Yijia2 (AUTHOR), Zhao, Mingyi1 (AUTHOR) |
| Source: | Pharmaceuticals (14248247). Jun2026, Vol. 19 Issue 6, p864. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
